9688.HK in “China Becomes Pharma's Global R&D Engine”
Zai Lab Limited
Its cross-border development infrastructure is well suited to moving medicines between Chinese and global markets.
9688.HK impact map — “China Becomes Pharma's Global R&D Engine”
How this story travels from the headline to 9688.HK’s own business — positive, negative or mixed, direct or indirect, the mechanism, and how strong the exposure is.
Loading 9688.HK impact map…
Price history, marked with story events
Oct 20, 2025 – Oct 19, 2026 · 221 sessions
Prices updated during market hours · refreshed about every 30 minutes while the market is open · delayed data, not for trading decisions
Numbered markers tie price moves to earnings, trial or study results, management comments and analyst or demand data. Loading events…
Full story
China Becomes Pharma's Global R&D Engine
Western drugmakers are licensing clinically validated Chinese molecules rather than relying solely on expensive in-house discovery.
BULL side — Its cross-border development infrastructure is well suited to moving medicines between Chinese and global markets.
Read the full China Becomes Pharma's Global R&D Engine story